Cargando…

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape

SIMPLE SUMMARY: Targeted therapy of solid tumors represents a great challenge because of heterogeneity of tumor-associated antigen expression. To overcome this obstacle we propose a dual targeting therapy based on protein preparations capable of recognizing different of tumor-associated antigens on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shramova, Elena, Proshkina, Galina, Shipunova, Victoria, Ryabova, Anastasia, Kamyshinsky, Roman, Konevega, Andrey, Schulga, Aleksey, Konovalova, Elena, Telegin, Georgij, Deyev, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602955/ https://www.ncbi.nlm.nih.gov/pubmed/33081407 http://dx.doi.org/10.3390/cancers12103014

Ejemplares similares

DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice
por: Proshkina, Galina M., et al.
Publicado: (2021)

Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors
por: Shramova, Elena I., et al.
Publicado: (2022)

Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology
por: Shilova, Olga, et al.
Publicado: (2021)

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model
por: Xu, Tianqi, et al.
Publicado: (2023)

On the prevention of kidney uptake of radiolabeled DARPins
por: Altai, Mohamed, et al.
Publicado: (2020)

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
por: Vorobyeva, Anzhelika, et al.
Publicado: (2020)

Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology
por: Shilova, Olga, et al.
Publicado: (2021)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
por: Vorobyeva, Anzhelika, et al.
Publicado: (2020)

Novel Small Multilamellar Liposomes Containing Large Quantities of Peptide Nucleic Acid Selectively Kill Breast Cancer Cells
por: Proshkina, Galina, et al.
Publicado: (2022)

The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth
por: Sokolova, E.A., et al.
Publicado: (2017)

Optimal composition and position of histidine-containing tags improves biodistribution of (99m)Tc-labeled DARPin G3
por: Vorobyeva, Anzhelika, et al.
Publicado: (2019)

Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
por: Sokolova, Evgeniya, et al.
Publicado: (2019)

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model
por: Sokolova, Evgeniya A., et al.
Publicado: (2019)

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
por: Deyev, Sergey M., et al.
Publicado: (2021)

Direct In Vivo Comparison of (99m)Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
por: Tolmachev, Vladimir, et al.
Publicado: (2022)

Phase I Trial of (99m)Tc-(HE)(3)-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer
por: Bragina, Olga, et al.
Publicado: (2022)

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
por: Vorobyeva, Anzhelika, et al.
Publicado: (2018)

Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with (99m)Tc for Radionuclide Imaging of HER2 Expression in Cancer
por: Larkina, Mariia, et al.
Publicado: (2022)

Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
por: Vorobyeva, Anzhelika, et al.
Publicado: (2019)

DARPins: Promising Scaffolds for Theranostics
por: Shilova, O. N., et al.
Publicado: (2019)

Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells
por: Xu, Tianqi, et al.
Publicado: (2022)

Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
por: Vorobyeva, Anzhelika, et al.
Publicado: (2019)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
por: Xu, Tianqi, et al.
Publicado: (2021)

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [(99m)Tc]Tc-ADAPT6 and [(99m)Tc]Tc-(HE)(3)-G3, for Imaging of HER2-Positive Breast Cancer
por: Bragina, Olga, et al.
Publicado: (2023)

Near-Infrared Activated Cyanine Dyes As Agents for Photothermal Therapy and Diagnosis of Tumors
por: Shramova, E. I., et al.
Publicado: (2020)

Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells In Vitro
por: Mironova, Kristina E., et al.
Publicado: (2013)

Flavoprotein miniSOG Cytotoxisity Can Be Induced By Bioluminescence Resonance Energy Transfer
por: Shramova, E.I., et al.
Publicado: (2016)

Switchable targeting of solid tumors by BsCAR T cells
por: Stepanov, Alexey V., et al.
Publicado: (2022)

Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery
por: Shipunova, Victoria O., et al.
Publicado: (2021)

Data on characterization of magnetic nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6
por: Shipunova, Victoria O., et al.
Publicado: (2018)

Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin
por: Becker, Lukas, et al.
Publicado: (2021)

A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits
por: Zeng, Yu, et al.
Publicado: (2022)

Data of self-made Taq DNA polymerase prepared for screening purposes
por: Konovalova, E.V., et al.
Publicado: (2017)

Beyond Antibodies: The DARPin(®) Drug Platform
por: Stumpp, Michael T., et al.
Publicado: (2020)

Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy
por: Shipunova, Victoria O., et al.
Publicado: (2023)

Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy
por: Kalinin, R. S., et al.
Publicado: (2023)

Artificial Scaffold Polypeptides As an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo
por: Shipunova, V. O., et al.
Publicado: (2022)

DARPins bind their cytosolic targets after having been translocated through the protective antigen pore of anthrax toxin
por: Becker, Lukas, et al.
Publicado: (2023)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
por: Karsten, Lennard, et al.
Publicado: (2022)

Programmable DARPin-based receptors for the detection of thrombotic markers
por: Strittmatter, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_drlp1d3gfhcudirsta9t5j9iio